Blosozumab (LY2541546) is a monoclonal antibody that targets human sclerostin (SOST), functioning as an inhibitor. This antibody promotes bone formation while concurrently decreasing bone resorption, making it a valuable tool in osteoporosis research. Blosozumab is specifically designed to elucidate the pathways and potential therapeutic effects related to bone density regulation and osteoporotic condition management.
Blosozumab (LY2541546) is a monoclonal antibody that targets human sclerostin (SOST), functioning as an inhibitor. This antibody promotes bone formation while concurrently decreasing bone resorption, making it a valuable tool in osteoporosis research. Blosozumab is specifically designed to elucidate the pathways and potential therapeutic effects related to bone density regulation and osteoporotic condition management.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
